The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for LC Chang


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importina-2 Expression, and Induce Antitumor Effects against Human Glioma.EBI
University of Hawaii At Hilo
Activity-guided isolation of steroidal alkaloid antiestrogen-binding site inhibitors from Pachysandra procumbens.EBI
University of Illinois At Chicago
A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.EBI
Leiden/Amsterdam Center For Drug Research
A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.EBI
Leiden/Amsterdam Center For Drug Research
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.EBI
University of Leiden
Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.EBI
National Taiwan University
2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research